China Universal Asset Management Company’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
|
|||||
|
2025
Q1 | $148K | Sell |
|
|||||
|
2024
Q4 | $252K | Buy |
|
|||||
|
2024
Q3 | $401K | Buy |
|
|||||
|
2024
Q2 | $254K | Sell |
|
|||||
|
2024
Q1 | $508K | Buy |
|
|||||
|
2023
Q4 | $316K | Buy |
|
|||||
|
2023
Q3 | $71.6K | Buy |
|
|||||
|
2023
Q2 | $47.1K | Sell |
|
|||||
|
2023
Q1 | $44.4K | Buy |
|
|||||
|
2022
Q4 | $33.3K | Buy |
|
|||||
|
2022
Q3 | $48K | Buy |
|
|||||
|
2022
Q2 | $8K | Hold |
|
|||||
|
2022
Q1 | $11K | Hold |
|
|||||
|
2021
Q4 | $18K | Buy |
|